Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

First-in-man use for new generation aortic aneurysm endograft system

Cook : 06 June, 2008  (New Product)
Cook Medical has announced its first-in-man use application of a smaller endograft system.
The successful case was the first human use of Cook's new Zenith Low Profile AAA Endograft System. Early reports indicate the new system, which uses more highly compressible Z-stent bodies instead of the existing stents used in the current Zenith Flex endografts, exceeded physician expectations.

“The successful development of this device will benefit TAA and AAA patients around the world for whom no endovascular treatment option currently exists,” explained Phil Nowell, global leader of Cook Medical's Aortic Intervention business unit. “The Zenith Low Profile represents yet another step forward by Cook Medical to provide physicians with the most advanced tools possible for the treatment of aortic disease in all its manifestations.”

The device miniaturisation development continues Cook's ongoing pursuit of developing technologies aimed at helping physicians perform minimally invasive diagnostic and therapeutic procedures with the least possible trauma to the patient.

Currently, delivery systems for endografts to treat aneurysms in the abdominal and thoracic regions of the aorta must be inserted through incisions in the femoral arteries because they are most often too large in diameter to be easily inserted percutaneously. The larger diameter sheath also means the device is stiffer, making it more difficult to negotiate through narrow, tightly curved arteries to reach the diseased section of the aorta where the endograft needs to be deployed. In addition, in smaller patients the vascular anatomy may be too small to accept the current generation of larger-sized delivery systems.

The Zenith Low Profile AAA Endograft System addresses those areas of concern by reducing the size of the delivery sheath to 16 French. This development, if proven safe and effective in an upcoming clinical trial, could open endovascular treatment of aneurysms to a new class of patients who currently have only open surgery as a treatment option due to the small diameter of their blood vessels and other anatomic issues. In addition, it may enable physicians to eliminate the need for a surgical cut down to access the femoral artery and allow the use of the percutaneous entry technique where a needle is inserted to allow the guidewire and delivery sheath to enter the artery with far less trauma.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo